Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection, Nature, vol.387, issue.6629, pp.183-188, 1997. ,
DOI : 10.1038/387183a0
In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency, Nature Medicine, vol.4, issue.12, pp.1284-1290, 1995. ,
DOI : 10.1038/373117a0
Decay characteristics of HIV-1-infected compartments during combination therapy, Nature, vol.387, issue.6629, pp.188-191, 1997. ,
DOI : 10.1038/387188a0
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia, Science, vol.278, issue.5341, pp.1291-1295, 1997. ,
DOI : 10.1126/science.278.5341.1291
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy, Nature Medicine, vol.6, issue.7, pp.757-761, 2000. ,
DOI : 10.1038/77481
HIV-1 rebound after anti-retroviral therapy, Nature Medicine, vol.6, issue.7, pp.736-737, 2000. ,
DOI : 10.1038/77447
Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy, Journal of Virology, vol.77, issue.5, pp.3229-3237, 2003. ,
DOI : 10.1128/JVI.77.5.3229-3237.2003
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells, Journal of Virology, vol.80, issue.13, pp.6441-6457, 2006. ,
DOI : 10.1128/JVI.00591-06
Characterization of the Follicular Dendritic Cell Reservoir of Human Immunodeficiency Virus Type 1, Journal of Virology, vol.82, issue.11, pp.5548-5561, 2008. ,
DOI : 10.1128/JVI.00124-08
Evidence for Human Immunodeficiency Virus Type 1 Replication In Vivo in CD14+ Monocytes and Its Potential Role as a Source of Virus in Patients on Highly Active Antiretroviral Therapy, Journal of Virology, vol.76, issue.2, pp.707-716, 2002. ,
DOI : 10.1128/JVI.76.2.707-716.2002
Cellular Reservoirs of HIV-1 and their Role in Viral Persistence, Current HIV Research, vol.6, issue.5, pp.388-400, 2008. ,
DOI : 10.2174/157016208785861195
HIV-1 Infection of Bone Marrow Hematopoietic Progenitor Cells and Their Role in Trafficking and Viral Dissemination, PLoS Pathogens, vol.27, issue.1, p.1000215, 2008. ,
DOI : 10.1371/journal.ppat.1000215.g003
HIV interactions with monocytes and dendritic cells: viral latency and reservoirs, Retrovirology, vol.6, issue.1, p.51, 2009. ,
DOI : 10.1186/1742-4690-6-51
The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection, Journal of Leukocyte Biology, vol.74, issue.5, pp.635-641, 2003. ,
DOI : 10.1189/jlb.0503204
Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection, Journal of Allergy and Clinical Immunology, vol.122, issue.1, pp.22-28, 2008. ,
DOI : 10.1016/j.jaci.2008.05.033
Infection of monocyte/macrophages by human T lymphotropic virus type III., Journal of Clinical Investigation, vol.77, issue.5, pp.1712-1715, 1986. ,
DOI : 10.1172/JCI112491
In vitro infection of human monocytes with human T lymphotropic virus type III/ lymphadenopathy-associated virus (HTLV-III/LAV), J Immunol, vol.137, pp.323-329, 1986. ,
Infectious HIV-1 assembles in late endosomes in primary macrophages, The Journal of Cell Biology, vol.2, issue.3, pp.443-455, 2003. ,
DOI : 10.1128/JVI.75.6.2982-2992.2001
Human Macrophages Accumulate HIV-1 Particles in MHC II Compartments, Traffic, vol.3, issue.10, pp.718-729, 2002. ,
DOI : 10.1034/j.1600-0854.2002.31004.x
The Cell Biology of HIV-1 Virion Genesis, Cell Host & Microbe, vol.5, issue.6, pp.550-558, 2009. ,
DOI : 10.1016/j.chom.2009.05.015
Perivascular Macrophages Are the Primary Cell Type Productively Infected by Simian Immunodeficiency Virus in the Brains of Macaques, The Journal of Experimental Medicine, vol.150, issue.8, pp.905-915, 2001. ,
DOI : 10.1126/science.2148832
Detection of Infectious HIV in Circulating Monocytes From Patients on Prolonged Highly Active Antiretroviral Therapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.23, issue.2, pp.114-119, 2000. ,
DOI : 10.1097/00126334-200002010-00002
Latent HIV-1 infection in enriched populations of blood monocytes and T cells from seropositive patients., Journal of Clinical Investigation, vol.87, issue.1, pp.27-30, 1991. ,
DOI : 10.1172/JCI114981
The CD16+ Monocyte Subset Is More Permissive to Infection and Preferentially Harbors HIV-1 In Vivo, The Journal of Immunology, vol.178, issue.10, pp.6581-6589, 2007. ,
DOI : 10.4049/jimmunol.178.10.6581
Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir, Antiviral Research, vol.55, issue.2, pp.209-225, 2002. ,
DOI : 10.1016/S0166-3542(02)00052-9
URL : http://www.sciencedirect.com/science?_ob=ShoppingCartURL&_method=add&_eid=1-s2.0-S0166354202000529&originContentFamily=serial&_origin=article&_ts=1480563639&md5=b87e5a8b5a33f7f560308ec361c32274
Novel drug resistance mutations in HIV: recognition and clinical relevance, AIDS Rev, vol.8, pp.179-190, 2006. ,
Gastrointestinal Tract as a Major Site of CD4+ T Cell Depletion and Viral Replication in SIV Infection, Science, vol.280, issue.5362, pp.427-431, 1998. ,
DOI : 10.1126/science.280.5362.427
Macrophage HIV-1 infection and the gastrointestinal tract reservoir, Journal of Leukocyte Biology, vol.74, issue.5, pp.642-649, 2003. ,
DOI : 10.1189/jlb.0503219
HIV-1 in peripheral blood monocytes: an underrated viral source, Journal of Antimicrobial Chemotherapy, vol.50, issue.3, pp.309-311, 2002. ,
DOI : 10.1093/jac/dkf143
Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques, Journal of Experimental Medicine, vol.183, issue.1, pp.215-225, 1996. ,
DOI : 10.1084/jem.183.1.215
Differential Susceptibility to Human Immunodeficiency Virus Type 1 Infection of Myeloid and Plasmacytoid Dendritic Cells, Journal of Virology, vol.79, issue.14, pp.8861-8869, 2005. ,
DOI : 10.1128/JVI.79.14.8861-8869.2005
T cells, The Journal of Experimental Medicine, vol.79, issue.12, pp.2023-2033, 2005. ,
DOI : 10.1182/blood-2003-07-2314
Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue, Science, vol.274, issue.5289, pp.985-989, 1996. ,
DOI : 10.1126/science.274.5289.985
Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART, AIDS Research and Human Retroviruses, vol.19, issue.12, pp.1097-1103, 2003. ,
DOI : 10.1089/088922203771881194
Therapeutic strategies towards HIV-1 infection in macrophages, Antiviral Research, vol.71, issue.2-3, pp.293-300, 2006. ,
DOI : 10.1016/j.antiviral.2006.05.015
Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1) ,
Macrophages as a Source of HIV During Opportunistic Infections, Science, vol.276, issue.5320, pp.1857-1861, 1997. ,
DOI : 10.1126/science.276.5320.1857
Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells, Blood, vol.106, issue.8, pp.2790-2797, 2005. ,
DOI : 10.1182/blood-2005-04-1390
AIDS, Annual Review of Neuroscience, vol.25, issue.1, pp.537-562, 2002. ,
DOI : 10.1146/annurev.neuro.25.112701.142822
URL : https://hal.archives-ouvertes.fr/hal-00590594
Microglia in human immunodeficiency virus-associated neurodegeneration, Glia, vol.22, issue.2, pp.240-251, 2002. ,
DOI : 10.1002/glia.10155
Bone marrow derived elements and resident microglia in brain inflammation, Glia, vol.16, issue.1, pp.19-24, 1993. ,
DOI : 10.1002/glia.440070106
CD34+ cells and their derivatives contain mRNA for CD4 and human immunodeficiency virus (HIV) ,
Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells, pp.3522-3528, 1997. ,
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by Tcell tropic human immunodeficiency virus, Blood, vol.94, pp.62-73, 1999. ,
Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow, Science, vol.242, issue.4880, pp.919-922, 1988. ,
DOI : 10.1126/science.2460922
Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults, Blood, vol.88, pp.3329-3335, 1996. ,
CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals, J Immunol, vol.149, pp.689-697, 1992. ,
CD14+CD16++ cells derivedin vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics, European Journal of Immunology, vol.30, issue.7, pp.1872-1883, 2000. ,
DOI : 10.1002/1521-4141(200007)30:7<1872::AID-IMMU1872>3.0.CO;2-2
Differentiation of Monocytes into Dendritic Cells in a Model of Transendothelial Trafficking, Science, vol.282, issue.5388, pp.480-483, 1998. ,
DOI : 10.1126/science.282.5388.480
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo, Immunity, vol.11, issue.6, pp.753-761, 1999. ,
DOI : 10.1016/S1074-7613(00)80149-1
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation, Embo J, vol.8, pp.765-778, 1989. ,
The Regulation of Human Immunodeficiency Virus Type-1 Gene Expression, European Journal of Biochemistry, vol.266, issue.3, pp.491-507, 1996. ,
DOI : 10.1016/0092-8674(89)90416-9
SURVEY AND SUMMARY A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter, Nucleic Acids Research, vol.28, issue.3, pp.663-668, 2000. ,
DOI : 10.1093/nar/28.3.663
Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells, Journal of Leukocyte Biology, vol.74, issue.5, pp.736-749, 2003. ,
DOI : 10.1189/jlb.0403180
HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4+ T lymphocytes, Journal of Leukocyte Biology, vol.87, issue.4, pp.575-88, 2009. ,
DOI : 10.1189/jlb.0409264
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes., Proceedings of the National Academy of Sciences, vol.89, issue.14, pp.6580-6584, 1992. ,
DOI : 10.1073/pnas.89.14.6580
Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells, Nature, vol.70, issue.7038, pp.108-114, 2005. ,
DOI : 10.1038/nature02171
Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes, J Virol, vol.73, pp.6526-6532, 1999. ,
Incompletely reversetranscribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle, J Virol, vol.66, pp.1717-1725, 1992. ,
HIV-1 Extrachromosomal 2-LTR Circular DNA Is Long-Lived in Human Macrophages, Viral Immunology, vol.18, issue.1, pp.190-196, 2005. ,
DOI : 10.1089/vim.2005.18.190
High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia
patients, Nature, vol.343, issue.6253, pp.85-89, 1990. ,
DOI : 10.1038/343085a0
T Cells, The Journal of Experimental Medicine, vol.63, issue.10, pp.1407-1419, 2001. ,
DOI : 10.1038/77481
Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA, Journal of Virology, vol.77, issue.7, pp.3962-3972, 2003. ,
DOI : 10.1128/JVI.77.7.3962-3972.2003
Human macrophages support persistent transcription from unintegrated HIV-1 DNA, Virology, vol.372, issue.2, pp.300-312, 2008. ,
DOI : 10.1016/j.virol.2007.11.007
Retroviral E-DNA: persistence and gene expression in nondividing immune cells, Journal of Leukocyte Biology, vol.80, issue.5, pp.1013-1017, 2006. ,
DOI : 10.1189/jlb.0306151
The multifactorial nature of HIV-1 latency, Trends in Molecular Medicine, vol.10, issue.11, pp.525-531, 2004. ,
DOI : 10.1016/j.molmed.2004.09.006
Latency: the hidden HIV-1 challenge, Retrovirology, vol.3, issue.1, p.7, 2006. ,
DOI : 10.1186/1742-4690-3-7
The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation, The EMBO Journal, vol.20, issue.7, pp.1726-1738, 2001. ,
DOI : 10.1093/emboj/20.7.1726
Orientation-Dependent Regulation of Integrated HIV-1 Expression by Host Gene Transcriptional Readthrough, Cell Host & Microbe, vol.4, issue.2, pp.134-146, 2008. ,
DOI : 10.1016/j.chom.2008.06.008
Transcriptional Interference Antagonizes Proviral Gene Expression to Promote HIV Latency, Cell Host & Microbe, vol.4, issue.2, pp.123-133, 2008. ,
DOI : 10.1016/j.chom.2008.05.016
P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in??vitro, Genes & Development, vol.11, issue.20, pp.2633-2644, 1997. ,
DOI : 10.1101/gad.11.20.2633
A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA, Cell, vol.92, issue.4, pp.451-462, 1998. ,
DOI : 10.1016/S0092-8674(00)80939-3
Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in??vitro, Genes & Development, vol.11, issue.20, pp.2622-2632, 1997. ,
DOI : 10.1101/gad.11.20.2622
HIV-1 infection and regulation of Tat function in macrophages, The International Journal of Biochemistry & Cell Biology, vol.36, issue.9, pp.1767-1775, 2004. ,
DOI : 10.1016/j.biocel.2004.02.018
Transcriptional Restriction of Human Immunodeficiency Virus Type 1 Gene Expression in Undifferentiated Primary Monocytes, Journal of Virology, vol.83, issue.8, pp.3518-3527, 2009. ,
DOI : 10.1128/JVI.02665-08
CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4+ T cells, Proceedings of the National Academy of Sciences, vol.94, issue.16, pp.8714-8719, 1997. ,
DOI : 10.1073/pnas.94.16.8714
C/EBP Activators Are Required for HIV-1 Replication and Proviral Induction in Monocytic Cell Lines, Immunity, vol.5, issue.1, pp.91-101, 1996. ,
DOI : 10.1016/S1074-7613(00)80313-1
Regulation of HIV-1 Gene Expression by NF-IL6, Journal of Molecular Biology, vol.262, issue.3, pp.327-335, 1996. ,
DOI : 10.1006/jmbi.1996.0516
Functional Interactions between C/EBP, Sp1, and COUP-TF Regulate Human Immunodeficiency Virus Type 1 Gene Transcription in Human Brain Cells, Journal of Virology, vol.74, issue.1, pp.65-73, 2000. ,
DOI : 10.1128/JVI.74.1.65-73.2000
Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein ?? Expression, The Journal of Immunology, vol.165, issue.4, pp.2028-2039, 2000. ,
DOI : 10.4049/jimmunol.165.4.2028
Mechanism for the Establishment of Transcriptional HIV Latency in the Brain in a Simian Immunodeficiency Virus???Macaque Model, The Journal of Infectious Diseases, vol.193, issue.7, pp.963-970, 2006. ,
DOI : 10.1086/500983
TRAF activation of C/EBP?? (NF-IL6) via p38 MAPK induces HIV-1 gene expression in monocytes/macrophages???, Microbes and Infection, vol.9, issue.6, pp.721-728, 2007. ,
DOI : 10.1016/j.micinf.2007.02.017
Molecular Characterization of a Putative Antiretroviral Transcriptional Factor, OTK18, The Journal of Immunology, vol.172, issue.1, pp.381-391, 2004. ,
DOI : 10.4049/jimmunol.172.1.381
OTK18, a zinc-finger protein, regulates human immunodeficiency virus type 1 long terminal repeat through two distinct regulatory regions, Journal of General Virology, vol.88, issue.1, pp.236-241, 2007. ,
DOI : 10.1099/vir.0.82066-0
Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors, Proceedings of the National Academy of Sciences, vol.100, issue.4, pp.1615-1620, 2003. ,
DOI : 10.1073/pnas.252770699
OTK18 expression in brain mononuclear phagocytes parallels the severity of HIV-1 encephalitis, Journal of Neuroimmunology, vol.150, issue.1-2, pp.186-198, 2004. ,
DOI : 10.1016/j.jneuroim.2004.01.021
YY1 and FoxD3 Regulate Antiretroviral Zinc Finger Protein OTK18 Promoter Activation Induced by HIV-1 Infection, Journal of Neuroimmune Pharmacology, vol.79, issue.1, pp.103-115, 2009. ,
DOI : 10.1007/s11481-008-9139-x
Inhibition of Human Immunodeficiency Virus Type 1 Replication with Artificial Transcription Factors Targeting the Highly Conserved Primer-Binding Site, Journal of Virology, vol.80, issue.6, pp.2873-2883, 2006. ,
DOI : 10.1128/JVI.80.6.2873-2883.2006
Step out of the Groove: Epigenetic Gene Control Systems and Engineered Transcription Factors, Adv Genet, vol.56, pp.163-204, 2006. ,
DOI : 10.1016/S0065-2660(06)56005-5
COUP-TF and Sp1 Interact and Cooperate in the Transcriptional Activation of the Human Immunodeficiency Virus Type 1 Long Terminal Repeat in Human Microglial Cells, Journal of Biological Chemistry, vol.272, issue.49, pp.31149-31155, 1997. ,
DOI : 10.1074/jbc.272.49.31149
Hydroxyurea and Interleukin-6 Synergistically Reactivate HIV-1 Replication in a Latently Infected Promonocytic Cell Line via SP1/SP3 Transcription Factors, Journal of Biological Chemistry, vol.282, issue.6, pp.3594-3604, 2007. ,
DOI : 10.1074/jbc.M608150200
SerpinB2 Is an Inducible Host Factor Involved in Enhancing HIV-1 Transcription and Replication, Journal of Biological Chemistry, vol.281, issue.42, pp.31348-31358, 2006. ,
DOI : 10.1074/jbc.M604220200
Role of chromatin in HIV-1 transcriptional regulation, Adv Pharmacol, vol.48, pp.121-160, 2000. ,
DOI : 10.1016/S1054-3589(00)48005-1
Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation, Embo J, vol.15, pp.1112-1120, 1996. ,
Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation, Embo J, vol.12, pp.3249-3259, 1993. ,
c-Myc and Sp1 Contribute to Proviral Latency by Recruiting Histone Deacetylase 1 to the Human Immunodeficiency Virus Type 1 Promoter, Journal of Virology, vol.81, issue.20, pp.10914-10923, 2007. ,
DOI : 10.1128/JVI.01208-07
Suv39H1 and HP1?? are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency, The EMBO Journal, vol.72, issue.2, pp.424-435, 2007. ,
DOI : 10.1038/sj.emboj.7601517
URL : https://hal.archives-ouvertes.fr/hal-00130455
Receptor tyrosine kinases and the regulation of macrophage activation, Journal of Leukocyte Biology, vol.75, issue.5, pp.731-737, 2004. ,
DOI : 10.1189/jlb.0703347
The Receptor Tyrosine Kinase RON Represses HIV-1 Transcription by Targeting RNA Polymerase II Processivity, The Journal of Immunology, vol.180, issue.3, pp.1670-1677, 2008. ,
DOI : 10.4049/jimmunol.180.3.1670
RON Receptor Tyrosine Kinase, a Negative Regulator of Inflammation, Inhibits HIV-1 Transcription in Monocytes/Macrophages and Is Decreased in Brain Tissue from Patients with AIDS, The Journal of Immunology, vol.173, issue.11, pp.6864-6872, 2004. ,
DOI : 10.4049/jimmunol.173.11.6864
Genotypic Analysis of HIV???1 Drug Resistance at the Limit of Detection: Virus Production without Evolution in Treated Adults with Undetectable HIV Loads, The Journal of Infectious Diseases, vol.189, issue.8, pp.1452-1465, 2004. ,
DOI : 10.1086/382488
Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing, The EMBO Journal, vol.190, issue.2, pp.412-423, 2007. ,
DOI : 10.1038/sj.emboj.7601516
Isolation of a Novel Family of C2H2 Zinc Finger Proteins Implicated in Transcriptional Repression Mediated by Chicken Ovalbumin Upstream Promoter Transcription Factor (COUP-TF) Orphan Nuclear Receptors, Journal of Biological Chemistry, vol.275, issue.14, pp.10315-10322, 2000. ,
DOI : 10.1074/jbc.275.14.10315
CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis, Gene Expression Patterns, vol.4, issue.6, pp.1733-739, 2004. ,
DOI : 10.1016/j.modgep.2004.03.009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819357
COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells, Nucleic Acids Research, vol.33, issue.7, pp.2318-2331, 2005. ,
DOI : 10.1093/nar/gki529
Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells, Journal of Virology, vol.77, issue.9, pp.5415-5427, 2003. ,
DOI : 10.1128/JVI.77.9.5415-5427.2003
Cell Cycle Arrest in G2 Induces Human Immunodeficiency Virus Type 1 Transcriptional Activation through Histone Acetylation and Recruitment of CBP, NF-??B, and c-Jun to the Long Terminal Repeat Promoter, Journal of Virology, vol.78, issue.22, pp.12198-12206, 2004. ,
DOI : 10.1128/JVI.78.22.12198-12206.2004
Human Immunodeficiency Virus Type 1-Induced Macrophage Gene Expression Includes the p21 Gene, a Target for Viral Regulation, Journal of Virology, vol.79, issue.7, pp.4479-4491, 2005. ,
DOI : 10.1128/JVI.79.7.4479-4491.2005
(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1, Oncogene, vol.28, pp.213380-213389, 2009. ,
DOI : 10.1038/onc.2009.193
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438893
The CDK Inhibitor p21Cip1/WAF1 Is Induced by Fc??R Activation and Restricts the Replication of Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses in Human Macrophages, Journal of Virology, vol.83, issue.23, pp.12253-65, 2009. ,
DOI : 10.1128/JVI.01395-09
Revisiting the principles of microRNA target recognition and mode of action, Nature Reviews Molecular Cell Biology, vol.125, issue.2, pp.141-148, 2009. ,
DOI : 10.1038/nrm2619
URL : https://hal.archives-ouvertes.fr/hal-00370008
The regulation of genes and genomes by small RNAs, Development, vol.134, issue.9, pp.1635-1641, 2007. ,
DOI : 10.1242/dev.002006
MicroRNAs, Cell, vol.116, issue.2, pp.281-297, 2004. ,
DOI : 10.1016/S0092-8674(04)00045-5
URL : https://hal.archives-ouvertes.fr/hal-00369966
Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?, Retrovirology, vol.4, issue.1, p.74, 2007. ,
DOI : 10.1186/1742-4690-4-74
URL : https://hal.archives-ouvertes.fr/hal-00194073
Insights into cellular microRNAs and human immunodeficiency virus type 1 (HIV-1), Journal of Cellular Physiology, vol.4, issue.2, pp.327-331, 2008. ,
DOI : 10.1002/jcp.21488
Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication, Science, vol.315, issue.5818, pp.1579-1582, 2007. ,
DOI : 10.1126/science.1136319
URL : https://hal.archives-ouvertes.fr/hal-00138482
Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes, Nature Medicine, vol.7, issue.10, pp.1241-1247, 2007. ,
DOI : 10.1038/nm1639
Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection, Blood, vol.113, issue.3, pp.671-674, 2009. ,
DOI : 10.1182/blood-2008-09-175000
miR-198 Inhibits HIV-1 Gene Expression and Replication in Monocytes and Its Mechanism of Action Appears To Involve Repression of Cyclin T1, PLoS Pathogens, vol.70, issue.1, p.1000263, 2009. ,
DOI : 10.1371/journal.ppat.1000263.g008
Interleukin-10 inhibits HIV-1 LTR-directed gene expression in human macrophages through the induction of cyclin T1 proteolysis, Virology, vol.352, issue.2, pp.485-492, 2006. ,
DOI : 10.1016/j.virol.2006.05.013
Signal transduction induced by apoptotic cells inhibits HIV transcription in monocytes/macrophages, Journal of Leukocyte Biology, vol.80, issue.4, pp.953-960, 2006. ,
DOI : 10.1189/jlb.1105638
An Essential Role for NF-kappa B in Preventing TNF-alpha -Induced Cell Death, Science, vol.274, issue.5288, pp.782-784, 1996. ,
DOI : 10.1126/science.274.5288.782
Suppression of TNF-alpha -Induced Apoptosis by NF-kappa B, Science, vol.274, issue.5288, pp.787-789, 1996. ,
DOI : 10.1126/science.274.5288.787
Activation of NF-??B by R5 and X4 Human Immunodeficiency Virus Type 1 Induces Macrophage Inflammatory Protein 1?? and Tumor Necrosis Factor Alpha in Macrophages, Journal of Virology, vol.76, issue.10, pp.5274-5277, 2002. ,
DOI : 10.1128/JVI.76.10.5274-5277.2002
Ikappakappa mediates NFkappaB activation in human immunodeficiency virus-infected cells, J Virol, vol.73, pp.3893-3903, 1999. ,
Regulation of I kappa B alpha and p105 in monocytes and Page, p.16 ,
Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T-or monocytic cell lines, J Virol, vol.72, pp.9698-9705, 1998. ,
Redox and activation status of monocytes from human immunodeficiency virus-infected patients: relationship with viral load, J Virol, vol.73, pp.4561-4566, 1999. ,
Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF, Virology, vol.329, issue.2, pp.371-380, 2004. ,
DOI : 10.1016/j.virol.2004.08.030
In Vitro Treatment of Human Monocytes/Macrophages with Myristoylated Recombinant Nef of Human Immunodeficiency Virus Type 1 Leads to the Activation of Mitogen-Activated Protein Kinases, I??B Kinases, and Interferon Regulatory Factor 3 and to the Release of Beta Interferon, Journal of Virology, vol.81, issue.6, pp.2777-2791, 2007. ,
DOI : 10.1128/JVI.01640-06
Exogenous Nef Protein Activates NF-kappa B, AP-1, and c-Jun N-Terminal Kinase and Stimulates HIV Transcription in Promonocytic Cells. ROLE IN AIDS PATHOGENESIS, Journal of Biological Chemistry, vol.278, issue.4, pp.2219-2227, 2003. ,
DOI : 10.1074/jbc.M209622200
HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell, Nature, vol.410, issue.6830, pp.834-838, 2001. ,
DOI : 10.1038/35071111
HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis, Experimental Cell Research, vol.312, issue.6, pp.890-900, 2006. ,
DOI : 10.1016/j.yexcr.2005.12.003
HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce antiapoptotic signals, Nature Medicine, vol.7, issue.11, pp.1217-1224, 2001. ,
DOI : 10.1038/nm1101-1217
Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated Apoptosis, Journal of Virology, vol.76, issue.6, pp.2692-2702, 2002. ,
DOI : 10.1128/JVI.76.6.2692-2702.2002
Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages, Proceedings of the National Academy of Sciences, vol.96, issue.9, pp.5215-5220, 1999. ,
DOI : 10.1073/pnas.96.9.5215
Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner, Current Biology, vol.9, issue.12, pp.622-631, 1999. ,
DOI : 10.1016/S0960-9822(99)80284-X
Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements, Journal of General Virology, vol.75, issue.7, pp.751597-1603, 1994. ,
DOI : 10.1099/0022-1317-75-7-1597
Kinetics of human immunodeficiency virus type 1 reverse transcription in blood mononuclear phagocytes are slowed by limitations of nucleotide precursors, J Virol, vol.68, pp.1258-1263, 1994. ,
Apoptotic death of striatal neurons induced by human immunodeficiency virus-1 Tat and gp120: Differential involvement of caspase-3 and endonuclease G, Journal of Neurovirology, vol.10, issue.3, pp.141-151, 2004. ,
DOI : 10.1080/13550280490441103
Long-term survival and virus production in human primary macrophages infected by human immunodeficiency virus, Journal of Medical Virology, vol.106, issue.4, pp.479-488, 2002. ,
DOI : 10.1002/jmv.10245
Infection of Human Immunodeficiency Virus and Intracellular Viral Tat Protein Exert a Pro-survival Effect in a Human Microglial Cell Line, Journal of Molecular Biology, vol.366, issue.1, pp.67-81, 2007. ,
DOI : 10.1016/j.jmb.2006.11.011
HIV-1 Persistence, Viral Reservoir, and the Central Nervous System in the HAART Era, Brain Pathology, vol.340, issue.1, pp.95-103, 2003. ,
DOI : 10.1111/j.1750-3639.2003.tb00010.x
HIV Tat Protein Increases Bcl-2 Expression in Monocytes Which Inhibits Monocyte Apoptosis Induced by Tumor Necrosis Factor-Alpha-Related Apoptosis-Induced Ligand, Intervirology, vol.50, issue.3, pp.224-228, 2007. ,
DOI : 10.1159/000100565
Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages, Oncogene, vol.300, issue.40, pp.5840-50, 2007. ,
DOI : 10.1038/sj.onc.1210388
Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons, Journal of Neurovirology, vol.8, issue.2, pp.86-99, 2002. ,
DOI : 10.1080/13550280290049552
Evidence for a cytopathogenicity determinant in HIV-1 Vpr, Proceedings of the National Academy of Sciences, vol.99, issue.14, pp.9503-9508, 2002. ,
DOI : 10.1073/pnas.142313699
Human Immunodeficiency Virus Type 1 Vpr Induces Apoptosis through Caspase Activation, Journal of Virology, vol.74, issue.7, pp.3105-3111, 2000. ,
DOI : 10.1128/JVI.74.7.3105-3111.2000
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC111809/pdf
Circulating Monocytes in HIV-1-Infected Viremic Subjects Exhibit an Antiapoptosis Gene Signature and Virus- and Host-Mediated Apoptosis Resistance, The Journal of Immunology, vol.182, issue.7, pp.4459-4470, 2009. ,
DOI : 10.4049/jimmunol.0801450
Is p21 an oncogene? Mol Cancer Ther, pp.1385-1386, 2006. ,
DOI : 10.1158/1535-7163.mct-06-0163
WAF1/CIP1) May Be a Tumor Suppressor After All, Cancer Biol Ther, p.216, 2007. ,
Apoptotic Killing of HIV-1???Infected Macrophages Is Subverted by the Viral Envelope Glycoprotein, PLoS Pathogens, vol.167, issue.9, pp.1281-1290, 2007. ,
DOI : 10.1371/journal.ppat.0030134.sg004
Delta32/Delta32 Stem-Cell Transplantation, New England Journal of Medicine, vol.360, issue.7, pp.692-698, 2009. ,
DOI : 10.1056/NEJMoa0802905
HIV-1 TAR RNA Subverts RNA Interference in Transfected Cells through Sequestration of TAR RNA-binding Protein, TRBP, Journal of Biological Chemistry, vol.281, issue.38, pp.27674-27678, 2006. ,
DOI : 10.1074/jbc.C600072200
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression, Retrovirology, vol.6, issue.1, p.18, 2009. ,
DOI : 10.1186/1742-4690-6-18
HIV Pharmacology: Barriers to the Eradication of HIV from the CNS, HIV Clinical Trials, vol.11, issue.7, pp.142-153, 2006. ,
DOI : 10.1097/00002030-200004140-00005
Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system, Advanced Drug Delivery Reviews, vol.39, issue.1-3, pp.5-31, 1999. ,
DOI : 10.1016/S0169-409X(99)00017-4
Discrepancies between Protease Inhibitor Concentrations and Viral Load in Reservoirs and Sanctuary Sites in Human Immunodeficiency Virus-Infected Patients, Antimicrobial Agents and Chemotherapy, vol.47, issue.1, pp.238-243, 2003. ,
DOI : 10.1128/AAC.47.1.238-243.2003
Relative Potency of Protease Inhibitors in Monocytes/Macrophages Acutely and Chronically Infected with Human Immunodeficiency Virus, Journal of Infectious Diseases, vol.178, issue.2, pp.413-422, 1998. ,
DOI : 10.1086/515642
HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy, JAMA, vol.286, issue.2, pp.196-207, 2001. ,
DOI : 10.1001/jama.286.2.196
Intermittent HIV-1 Viremia (Blips) and Drug Resistance in Patients Receiving HAART, JAMA, vol.293, issue.7, pp.817-829, 2005. ,
DOI : 10.1001/jama.293.7.817
Recent status of HIV-1 gene expression inhibitors, Antiviral Research, vol.71, issue.2-3, pp.301-306, 2006. ,
DOI : 10.1016/j.antiviral.2006.01.002
Tat as a transcriptional activator and a potential therapeutic target for HIV-I, Adv Pharmacol, vol.48, pp.209-227, 2000. ,
DOI : 10.1016/S1054-3589(00)48007-5
The regulation of HIV-1 transcription: Molecular targets for chemotherapeutic intervention, Medicinal Research Reviews, vol.79, issue.5, pp.595-625, 2006. ,
DOI : 10.1002/med.20081
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies, Journal of Leukocyte Biology, vol.80, issue.5, pp.1103-1110, 2006. ,
DOI : 10.1189/jlb.0606376
Stimulated trans-acting factor of 50??kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages, Virology, vol.356, issue.1-2, pp.79-94, 2006. ,
DOI : 10.1016/j.virol.2006.07.025
Naturally occurring C-terminally truncated STAT5 is a negative regulator of HIV-1 expression, Blood, vol.109, issue.12, pp.5380-5389, 2007. ,
DOI : 10.1182/blood-2006-08-042556
Thioredoxin Reductase-1 Negatively Regulates HIV-1 Transactivating Protein Tat-dependent Transcription in Human Macrophages, Journal of Biological Chemistry, vol.283, issue.48, pp.33183-33190, 2008. ,
DOI : 10.1074/jbc.M807403200
Novel Function of Prothymosin Alpha as a Potent Inhibitor of Human Immunodeficiency Virus Type 1 Gene Expression in Primary Macrophages, Journal of Virology, vol.80, issue.18, pp.9200-9206, 2006. ,
DOI : 10.1128/JVI.00589-06
NFAT5 Regulates HIV-1 in Primary Monocytes via a Highly Conserved Long Terminal Repeat Site, PLoS Pathogens, vol.9, issue.12, p.130, 2006. ,
DOI : 10.1371/journal.ppat.0020130.sg001
Interleukin-10 Induces Inhibitory C/EBP?? through STAT-3 and Represses HIV-1 Transcription in Macrophages, American Journal of Respiratory Cell and Molecular Biology, vol.33, issue.4, pp.406-411, 2005. ,
DOI : 10.1165/rcmb.2005-0140OC
O-Linked N-Acetylglucosaminylation of Sp1 Inhibits the Human Immunodeficiency Virus Type 1 Promoter, Journal of Virology, vol.83, issue.8, pp.3704-3718, 2009. ,
DOI : 10.1128/JVI.01384-08
OTK18 Levels in Plasma and Cerebrospinal Fluid Correlate with Viral Load and CD8 T-cells in Normal and AIDS Patients, Journal of Neuroimmune Pharmacology, vol.4, issue.Suppl 1, pp.230-235, 2008. ,
DOI : 10.1007/s11481-008-9125-3
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy, AIDS, vol.13, issue.17, pp.2405-2410, 1999. ,
DOI : 10.1097/00002030-199912030-00012
Isolation of a cellular factor that can reactivate latent HIV-1 without T cell activation, Proceedings of the National Academy of Sciences, vol.106, issue.15, pp.6321-6326, 2009. ,
DOI : 10.1073/pnas.0809536106
Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection, PLoS ONE, vol.4, issue.6, p.6093, 2009. ,
DOI : 10.1371/journal.pone.0006093.s008
URL : https://hal.archives-ouvertes.fr/hal-00464770
Epigenetic Regulation of HIV-1 Latency by Cytosine Methylation, PLoS Pathogens, vol.20, issue.6, p.1000495, 2009. ,
DOI : 10.1371/journal.ppat.1000495.s009
A Double???Blind, Placebo???Controlled Trial of Maraviroc in Treatment???Experienced Patients Infected with Non???R5 HIV???1, The Journal of Infectious Diseases, vol.199, issue.11, pp.1638-1647, 2009. ,
DOI : 10.1086/598965
HIV-1 entry inhibitors: an overview, Current Opinion in HIV and AIDS, vol.4, issue.2, pp.82-87, 2009. ,
DOI : 10.1097/COH.0b013e328322402e
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753507
Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy, Retrovirology, vol.5, issue.1, p.11, 2008. ,
DOI : 10.1186/1742-4690-5-11
URL : http://doi.org/10.1186/1742-4690-5-11